5778
B. Riflade et al. / Tetrahedron 69 (2013) 5772e5779
(t, J¼7.7 Hz CH2Me), 1.01e0.97 (m, 57.6H, N(CH2CH2CH2Me)4). 13C
arom.), 140.4 (CH arom.), 139.6 (CH arom.), 136.5 (CH arom.), 128.1
(C arom.), 126.8 (CH arom.), 122.6 (CH arom.), 121.4 (C arom.), 88.7
(CH2OV), 62.9 (CNH), 59.2 (N(CH2CH2CH2Me)4), 35.7 (Me2NH2),
28.5 (CH2Me), 23.1 (N(CH2CH2CH2Me)4), 19.2 (N(CH2CH2CH2Me)4),
13.5 (N(CH2CH2CH2Me)4), 7.2 (CH2Me). 31P NMR (162 MHz,
NMR (100 MHz, CD3CN):
d
¼179.1 (C]O), 158.1 (C arom.), 145.9 (C
arom.), 140.7 (CH arom.),138.1 (C arom.), 131.2 (CH arom.), 130.0 (CH
arom.), 128.2 (CH arom.), 127.6 (CH arom.), 127.1 (CH arom.), 89.9
(CH2OV), 64.3 (CNH), 59.3 (N(CH2CH2CH2Me)4), 36.5 (Me2NH2), 29.1
(CH2Me), 24.5 (N(CH2CH2CH2Me)4), 20.4 (N(CH2CH2CH2Me)4), 14.1
(N(CH2CH2CH2Me)4), 7.1 (CH2Me). 31P NMR (162 MHz, CD3CN)
CD3CN)
d
¼ꢀ5.69 (s, 1P), ꢀ11.80 (s, 1P). Anal. Calcd for TBA4.7(-
Me2NH2)0.3C15H16N2O62P2V3W15 (5342.21 g molꢀ1): C 20.41, H
3.54, N 1.83; found: C 20.64, H 3.42, N 1.87.
d
¼ꢀ5.71 (s, 1P), ꢀ11.74 (s, 1P). Anal. Calcd for TBA4,8(-
Me2NH2)0.2C17H18N2O62P2V3W15 (5387.88 g molꢀ1): C 20.99, H 3.59,
N 1.81; found: C 21.23, H 3.65, N 1.83.
3.5. Palladacycle 20
3.4.2. POM ligand 15. Following GP1 from the diol-amide 10
(18.7 mg, 0.069 mmol). POM 15 was isolated as a yellow powder
POM 15 (100 mg, 0.019 mmol, 1 equiv) and Pd(OAc)2 (4 mg,
0.019 mmol, 1 equiv) were dissolved in CD3CN and transferred in
a sealed tube. The mixture was stirred for 5 min at rt and treated as
in GP1 to afford the pure functionalized POM 20 (91 mg,
(253 mg, 0.048 mmol, 83% yield). IR:
1484, 1380, 1086, 954, 900, 804, 760, 731 cmꢀ1. 1H NMR (400 MHz,
CD3CN):
n¼2962, 2874, 1623, 1582,
d¼11.39 (d, J¼6.7 Hz, 1H, NH), 8.71 (dd, J¼6.4, 2.2 Hz, 1H,
0.017 mmol, 89% yield). IR:
n
¼2963, 1581, 1484, 1382, 1087, 1052,
1024, 951, 904, 811, 734 cmꢀ1
.
1H NMR (400 MHz, DMSO-d6):
arom.), 8.27e8.25 (m, 4H, arom.), 7.59 (t, J¼7.7 Hz, 2H, arom.), 7.52
(dd, J¼7.7,1.2 Hz,1H, arom.), 6.79 (br s,1.2H, Me2NH2), 5.98 (A of AB,
J¼12.3 Hz, 2H, CHHOV), 5.64 (B of AB, J¼12.3 Hz, 2H, CHHOV), 4.61
(br s, 1H, CHNH), 3.16e3.13 (m, 32.5H, N(CH2CH2CH2Me)4), 2.96 (br
s, 3.6H, Me2NH2), 1.67e1.61 (m, 35.2H, N(CH2CH2CH2Me)4),
1.44e1.38 (m, 35.2H, N(CH2CH2CH2Me)4), 1.00e0.98 (m, 52.8H,
d
¼8.26 (br s, 1H, arom.), 8.10 (br s, 1H, arom.), 8.01 (d, J¼8.1 Hz, 1H,
arom.), 7.76 (br s, 1H, arom.), 7.20 (m, 3H, arom.), 5.71 (A of AB,
J¼11.8 Hz, 2H, CHHOV), 5.44 (B of AB, J¼11.8 Hz, 2H, CHHOV), 4.24
(br s, 1H, CHNH), 3.18e3.16 (m, 38.4H, N(CH2CH2CH2Me)4),
1.58e1.56 (m, 38.4H, N(CH2CH2CH2Me)4), 1.34e1.30 (m, 38.4H,
N(CH2CH2CH2Me)4), 0.94e0.92 (m, 57.6H, N(CH2CH2CH2Me)4).
N(CH2CH2CH2Me)4). 13C NMR (100 MHz, CD3CN):
d
¼179.6 (C]O),
13C NMR (100 MHz, DMSO-d6):
d
¼175.0 (C]O), 164.1 (C arom.),
158.4 (C arom.), 145.8 (C arom.), 140.5 (CH arom.), 138.1 (C arom.),
131.5 (CH arom.), 130.0 (CH arom.), 128.3 (CH arom.), 127.4 (CH
arom.), 127.3 (CH arom.), 85.7 (CH2OV), 59.3 (N(CH2CH2CH2Me)4),
57.2 (CNH), 36.8 (Me2NH2), 24.4 (N(CH2CH2CH2Me)4), 20.4
(N(CH2CH2CH2Me)4), 13.9 (N(CH2CH2CH2Me)4). 31P NMR (162 MHz,
151.2 (C arom.), 146.5 (C arom.), 141.7 (CH arom.), 133.5 (CH arom.),
130.6 (CH arom.), 126.1 (CH arom.), 125.4 (CH arom.), 124.6 (CH
arom.), 121.5 (CH arom.), 118.1 (CH3CN), 83.7 (CH2OV), 59.9
(CH), 57.4 (N(CH2CH2CH2Me)4), 23.1 (N(CH2CH2CH2Me)4), 19.2
(N(CH2CH2CH2Me)4), 13.5 (N(CH2CH2CH2Me)4), 0.7 (CH3CN). 31P
CD3CN)
d
¼ꢀ5.91 (s, 1P), ꢀ11.48 (s, 1P). Anal. Calcd for TBA4,4(-
Me2NH2)0.6C15H14N2O62P2V3W15 (5281.28 g molꢀ1): C 19.69, H
3.38, N 1.85; found: C 19.76, H 3.44, N 1.91.
NMR (162 MHz, CD3CN)
d
¼ꢀ5.99 (s, 1P), ꢀ11.96 (s, 1P). Anal. Calcd
for TBA4.8H0.2C15H12N2O62PdP2V3W15 (5348.80 g molꢀ1): C 20.61, H
3.48, N 1.78; found: C 20.82, H 3.48, N 1.85.
3.4.3. POM ligand 16. Following GP1 from the diol-amide 11
(18.7 mg, 0.069 mmol). POM 16 was isolated as a yellow powder
3.6. Heck reaction
(256 mg, 0.048 mmol, 86% yield). IR:
n
¼2955, 2890,1625,1578,1385,
1091, 951, 894, 755, 732 cmꢀ1. 1H NMR (400 MHz, CD3CN)
d¼8.87 (d,
Iodobenzene (110
styrene (228 L, 2 mmol, 2 equiv), the POM catalyst (0.01 mmol,
0.01 equiv) and Na2CO3 (127 mg, 1.2 mmol, 1.2 equiv) or Et3N
mL,1 mmol,1 equiv) was added to a mixture of
J¼7.7 Hz, 1H, arom.), 8.77 (d, J¼7.8 Hz, 1H, arom.), 8.74 (br s, 1H,
arom.), 8.54 (d, J¼7.7 Hz,1H, arom.), 8.27 (t, J¼7.8 Hz,1H, arom.), 8.03
(br s, 1H, arom.), 7.53 (br s, 1H, arom.), 5.66 (A of AB, J¼12.6 Hz, 2H,
CHHOH), 5.52 (B of AB, J¼12.6 Hz, 2H, CHHOH), 3.19e3.16 (m, 40H,
N(CH2CH2CH2Me)4), 2.02e2.01 (m, 2H, CH2Me), 1.65e161 (m, 40H,
N(CH2CH2CH2Me)4), 1.45e1.39 (m, 40H, N(CH2CH2CH2Me)4), 1.20 (t,
m
(162 mL, 1.2 mmol, 1.2 equiv) in 0.5 mL of DMF, DMSO or CH3CN. The
solution was over after 20 h at 80 ꢁC.
J¼7.8 Hz, 3H, CH2Me), 0.99e0.96 (m, 60H, N(CH2CH2CH2Me)4). 13
C
Acknowledgements
NMR (100 MHz, CD3CN):
d
¼178.9 (C]O), 156.9 (C arom.), 154.4 (C
ꢀ
We thank Universite P. et M. Curie (UPMC), CNRS and ANR (grant
arom.),153.3 (CH arom.),145.9 (CH arom.),140.6 (CH arom.),138.8 (C
arom.), 128.7 (CH arom.), 127.4 (CH arom.), 126.2 (CH arom.), 122.3
(CH arom.), 89.7 (CH2OV), 64.3 (CNH), 59.2 (N(CH2CH2CH2Me)4),
29.1 (CH2Me), 24.4 (N(CH2CH2CH2Me)4), 20.4 (N(CH2CH2CH2Me)4),
14.0 (N(CH2CH2CH2Me)4), 7.7 (CH2Me). 31P NMR (162 MHz, CD3CN)
number 08-PCVI-0005 to E.L., S.T. and B.H.) for funding. FR2769 is
acknowledged for technical assistance.
Supplementary data
d
¼ꢀ5.70 (s, 1P), ꢀ11.86 (s, 1P). Anal. Calcd for TBA5C16H17
-
N3O62P2V3W15 (5428.15 g molꢀ1): C 21.24, H 3.65, N 2.09; found: C
21.06, H 3.62, N 1.98.
NMR spectra of new compounds. Supplementary data
3.4.4. POM ligand 18. Following GP1 from the diol-amide 13
(18.9 mg, 0.069 mmol). POM 18 was isolated as a yellow powder
References and notes
(288 mg, 0.054 mmol, 93% yield). IR:
1483, 1087, 952, 901, 811, 731 cmꢀ1. 1H NMR (400 MHz, DMSO-d6):
¼14.89 (br s, 1H, NH), 9.34 (dd, J¼7.5, 1.7 Hz, 1H, arom.), 9.18 (dd,
n
¼2964, 2871, 1661, 1599,
1. (a) Hill, C. L. In Comprehensive Coordination Chemistry II; Wedd, A. G., Ed.;
Elsevier: Oxford, UK, 2004; Vol. 4, pp 679e759; (b) Pope, M. T. In Comprehensive
Coordination Chemistry II; Wedd, A. G., Ed.; Elsevier: Oxford, UK, 2004; Vol. 4,
pp 635e678; (c) Proust, A.; Thouvenot, R.; Gouzerh, P. Chem. Commun. 2008,
1837e1852; (e) Dolbecq, A.; Dumas, E.; Mayer, C. R.; Mialane, P. Chem. Rev. 2010,
110, 6009e6048; (f) Long, D.-L.; Tsunashima, R.; Cronin, L. Angew. Chem., Int. Ed.
2010, 49, 1736e1758; (g) Oms, O.; Dolbecq, A.; Mialane, P. Chem. Soc. Rev. 2012,
41, 7497e7536.
2. (a) Putaj, P.; Lefebvre, F. Coord. Chem. Rev. 2011, 255, 1642e1685; (b) Izarova, N.;
Pope, M. T.; Kortz, U. Angew. Chem., Int. Ed. 2012, 51, 9492e9510.
3. Knoth, W. H.; Domaille, P. J.; Harlow, R. L. Inorg. Chem. 1986, 25, 1577e1584.
4. Angus-Dunne, S.; Burns, R. C.; Craig, D. C.; Lawrance, G. A. J. Chem. Soc., Chem.
Commun. 1994, 523e524.
d
J¼4.4, 1.7 Hz, 1H, arom.), 8.82 (dd, J¼8.6, 1.4 Hz, 1H, arom.), 8.55
(dd, J¼8.6, 1.4 Hz, 1H, arom.), 8.15 (br s, 0.6H, Me2NH2), 7.89e7.83
(m, 2H, arom.), 6.83 (br s, 0.6H, Me2NH2), 5.54 (AB, J¼12.3 Hz, 4H,
CH2OV), 3.19e3.15 (m, 38.8H, N(CH2CH2CH2Me)4 and Me2NH2),
2.02 (q, J¼7.5 Hz, 2H, CH2Me), 1.62e1.54 (m, 37.6H,
N(CH2CH2CH2Me)4), 1.37e1.28 (m, 40.6H, N(CH2CH2CH2Me)4 and
CH2Me), 0.95e0.92 (m, 56.4H, N(CH2CH2CH2Me)4). 13C NMR
(100 MHz, DMSO-d6):
d
¼178.2 (C]O), 151.3 (CH arom.), 144.4 (C